Signaling mechanisms that mediate invasion in prostate cancer cells

L Bonaccorsi1, S Marchiani, M Muratori

  • 1Dipartimento di Fisiopatologia Clinica (Unità di Andrologia), University of Florence, Italy.

Insights

Androgen receptor expression in prostate cancer cells reduces epidermal growth factor receptor (EGFR) signaling, decreasing cell invasion. This suggests potential therapeutic strategies targeting EGFR for androgen-independent prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Androgen-sensitive prostate cancer cells exhibit reduced migration and invasion.
  • The role of androgen receptors (AR) in modulating epidermal growth factor receptor (EGFR) signaling is not fully understood.

Purpose of the Study:

  • To investigate how androgen receptor presence affects EGFR-mediated signaling pathways in prostate cancer cells.
  • To evaluate the impact of AR on EGFR autophosphorylation and downstream PI3K/AKT pathway activation.
  • To assess the therapeutic potential of EGFR inhibition in androgen-independent prostate cancer.

Main Methods:

  • Immunoprecipitation studies to assess EGFR tyrosine phosphorylation.
  • Measurement of PI3K activity in response to EGF stimulation.
  • In vitro invasion assays using Matrigel.
  • Treatment with gefitinib (EGFR inhibitor) and R1881 (androgen agonist).

Main Results:

  • PC3 cells transfected with AR (PC3-AR) showed reduced EGF-induced EGFR tyrosine phosphorylation.
  • EGF-stimulated PI3K activity was decreased in PC3-AR cells and further reduced by R1881.
  • Gefitinib inhibited EGFR autotransphosphorylation and PI3K activation in androgen-insensitive cell lines (PC3, DU145), reducing in vitro invasion.

Conclusions:

  • Androgen receptor expression confers a less malignant phenotype by interfering with EGFR signaling and reducing invasion.
  • EGFR inhibition using gefitinib can decrease invasion and proliferation in androgen-independent prostate cancer.
  • Targeting EGFR may be a viable strategy for treating advanced prostate cancer.

Related Concept Videos

Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...